Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients-A prospective cohort study

Nephrology Dialysis Transplantation

Volumn 27, Issue 3, 2012, Pages 1169-1175

  Wu, I Wen ^a,b   Hsu, Kuang Hung ^c   Hsu, Heng Jung ^a,b   Lee, Chin Chan ^a,b   Sun, Chiao Yin ^a,b   Tsai, Chi Jen ^a,b   Wu, Mai Szu ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Elderly; Hemodialysis; Indoxyl sulfate; Mortality; P cresyl sulfate

Indexed keywords

4 CRESYL SULFATE; ALBUMIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; HEMOGLOBIN; INDICAN; PARATHYROID HORMONE; UNCLASSIFIED DRUG;

AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; CAUSE OF DEATH; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ELDERLY CARE; FEMALE; FOLLOW UP; HEART DEATH; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SURVIVAL RATE; UREMIA;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CRESOLS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PROGNOSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; SULFURIC ACID ESTERS; SURVIVAL RATE;

EID: 84861145050     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr453     Document Type: Article

References (30)

1. USRDS. Excerpts from USRDS 2009 Annual Data Report. U.S. Department of Health and Human Services. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Am J Kidney Dis 2010; 55 (Suppl 1): S1-S420
2. Joly D, Anglicheau D, Alberti C et al. Octogenarians reaching endstage renal disease: cohort study of decision-making and clinical outcomes. J Am Soc Nephrol 2003; 14: 1012-1021
3. Kurella Tamura M, Covinsky KE, Chertow GM et al. Functional status of elderly adults before and after initiation of dialysis. N Engl J Med 2009; 361: 1539-1547
4. Kurella M, Covinsky KE, Collins AJ et al. Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med 2007; 146: 177-183
5. Chauveau P, Combe C, LavilleMet al. Factors influencing survival in hemodialysis patients aged older than 75 years: 2.5-year outcome study. Am J Kidney Dis 2001; 37: 997-1003
6. Couchoud C, Labeeuw M, Moranne O et al. A clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal disease. Nephrol Dial Transplant 2009; 24: 1553-1561
7. Liabeuf S, Barreto DV, Barreto FC et al. Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease. Nephrol Dial Transplant 2009; 25: 1183-1191
8. Bammens B, Evenepoel P, Keuleers H et al. Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int 2006; 69: 1081-1087
9. Barreto FC, Barreto DV, Liabeuf S et al. Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol 2009; 4: 1551-1558
10. Lin CJ, Wu CJ, Pan CF et al. Serum protein-bound uraemic toxins and clinical outcomes in haemodialysis patients. Nephrol Dial Transplant 2010; 25: 3693-3700
11. Wu IW, Hsu KH, Lee CC et al. p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease. Nephrol Dial Transplant 2010; 26: 938-947
12. Lee CT, Kuo CC, Chen YM et al. Factors associated with blood concentration of indoxyl sulfate and p-cresol in patients undergoing peritoneal dialysis. Perit Dial Int 2010; 30: 456-463
13. Winkelmayer WC, Glynn RJ, Mittleman MA et al. Comparing mortality of elderly patients on hemodialysis versus peritoneal dialysis: a propensity score approach. J Am Soc Nephrol 2002; 13: 2353-2362
14. Meijers BKI, Claes K, Bammens B et al. p-Cresol and cardiovascular risk in mild-to-moderate kidney disease. Clin J Am Soc Nephrol 2010; 5: 1182-1189
15. Meijers BK, Van Kerckhoven S, Verbeke K et al. The uremic retention solute p-cresyl sulfate and markers of endothelial damage. Am J Kidney Dis 2009; 54: 891-901
16. Meijers BK, Bammens B, De Moor B et al. Free p-cresol is associated with cardiovascular disease in hemodialysis patients. Kidney Int 2008; 73: 1174-1180
17. Yu M, Kim YJ, Kang DH. Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress. Clin J Am Soc Nephrol 2010; 6: 30-39
18. Tumur Z, Shimizu H, Enomoto A et al. Indoxyl sulfate upregulates expression of ICAM-1 and MCP-1 by oxidative stress-induced NF-kappaB activation. Am J Nephrol 2010; 31: 435-441
19. Palm F, NangakuM, Fasching A et al. Uremia induces abnormal oxygen consumption in tubules and aggravates chronic hypoxia of the kidney via oxidative stress. Am J Physiol Renal Physiol 2010; 299: F380-F386
20. Kawakami T, Inagi R, Wada T et al. Indoxyl sulfate inhibits proliferation of human proximal tubular cells via endoplasmic reticulum stress. Am J Physiol Renal Physiol 2010; 299: F568-F576
21. Shimizu H, Bolati D, Adijiang A et al. Senescence and dysfunction of proximal tubular cells are associated with activated p.53 expression by indoxyl sulfate. Am J Physiol Cell Physiol 2010; 299: C1110-C1117
22. Schepers E, Meert N, Glorieux G et al. P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production. Nephrol Dial Transplant 2007; 22: 592-596
23. Wang CP, Lu LF, Yu TH et al. Serum levels of total p-cresylsulphate are associated with angiographic coronary atherosclerosis severity in stable angina patients with early stage of renal failure. Atherosclerosis 2010; 211: 579-583
24. Adijiang A, Niwa T. An oral sorbent, AST-120, increases Klotho expression and inhibits cell senescence in the kidney of uremic rats. Am J Nephrol 2010; 31: 160-164
25. Marquez IO, Tambra S, Luo FY et al. Contribution of residual function to removal of protein-bound solutes in hemodialysis. Clin J Am Soc Nephrol 2011; 6: 290-296
26. Meijers BK, De Loor H, Bammens B et al. p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients. Clin J Am Soc Nephrol 2009; 4: 1932-1938
27. Niwa T, Ise M, Miyazaki T et al. Suppressive effect of an oral sorbent on the accumulation of p-cresol in the serum of experimental uremic rats. Nephron 1993; 65: 82-87
28. Nakabayashi I, Nakamura M, Kawakami K et al. Effects of symbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study. Nephrol Dial Transplant 2010; 26: 1094-1098
29. Luo FJ, Patel KP, Marquez IO et al. Effect of increasing dialyzer mass transfer area coefficient and dialysate flow on clearance of proteinbound solutes: a pilot crossover trial. Am J Kidney Dis 2009; 53: 1042-1049
30. Meyer TW, Peattie JW, Miller JD et al. Increasing the clearance of protein-bound solutes by addition of a sorbent to the dialysate. J Am Soc Nephrol 2007; 18: 868-874